Targeting Small-Conductance Calcium-Activated Potassium Channels in Atrial Fibrillation: Therapeutic Opportunities

Circ Res. 2023 Apr 28;132(9):1104-1106. doi: 10.1161/CIRCRESAHA.123.322777. Epub 2023 Apr 27.

Authors

Xiao-Dong Zhang¹, Nipavan Chiamvimonvat^{1

2

3}

Affiliations

¹ Division of Cardiovascular Medicine, Department of Internal Medicine (X.-D.Z., N.C.), School of Medicine, University of California, Davis.
² Department of Pharmacology (N.C.), School of Medicine, University of California, Davis.
³ Department of Veterans Affairs, Northern California Health Care System, Mather (N.C.).

No abstract available

Keywords: Editorial; atrial fibrillation; heart; humans; small-conductance calcium-activated potassium channels.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, N.I.H., Extramural
Comment

MeSH terms

Atrial Fibrillation* / drug therapy
Heart Atria
Humans
Small-Conductance Calcium-Activated Potassium Channels

Substances

Small-Conductance Calcium-Activated Potassium Channels

Grants and funding